Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online January 30, 2008
Diabetes Care 31:789-794, 2008
DOI: 10.2337/dc07-1788
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1788v1
31/4/789    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnet, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnet, F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Research

Influence of the ACE Gene Insertion/Deletion Polymorphism on Insulin Sensitivity and Impaired Glucose Tolerance in Healthy Subjects

Fabrice Bonnet, MD, PHD1,2, Sheila Patel, PHD3, Martine Laville, MD, PHD2, Beverley Balkau, PHD4,5, Angela Favuzzi, MD6, Lucilla D. Monti, MD7, Nebojsa Lalic, MD8, Mark Walker, MD, PHD9 on behalf of the European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group

1 Department of Medicine, Endocrinology Unit, Centre Hospitalier Universitaire (CHU), Université Rennes, Rennes, France
2 Centre de Recherche en Nutrition Humaine Rhône-Alpes, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de la Recherche Agronomique, Université Lyon, Hospices Civils de Lyon, Lyon, France
3 Cardiovascular Endocrine Group, Department of Medicine, University of Melbourne, Melbourne, Australia
4 INSERM U780, Villejuif, France
5 Universitaire Paris-Sud, Orsay, France
6 Department of Internal Medicine, Catholic University, "S. Cuore," Rome, Italy
7 Diabetology, Endocrinology, and Metabolic Disease Unit, Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy
8 Institute for Endocrinology, Diabetes, and Metabolic Diseases, University of Belgrade, Belgrade, Serbia
9 Department of Diabetes, School of Clinical Medical Sciences, University of Newcastle, Newcastle, U.K

Address correspondence and reprint requests to Dr. Fabrice Bonnet, Department of Endocrinology, CHU Rennes, University of Rennes 1, 35002 Rennes, France. E-mail: fabrice.bonnet{at}chu-rennes.fr

OBJECTIVE—Recent studies suggested that the blockade of the renin-angiotensin system (RAS) may be associated with metabolic benefits. However, data about the potential influence of the ACE insertion/deletion (I/D) genotype on insulin resistance have been contradictory with studies of limited sample sizes. The purpose of this study was to investigate the relationship between the ACE gene I/D polymorphism and both insulin sensitivity and glucose intolerance in a large cohort of healthy subjects.

RESEARCH DESIGN AND METHODS—A total of 1,286 participants in the Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study had a 75-g oral glucose tolerance test and a hyperinsulinemic-euglycemic clamp to assess whole-body insulin sensitivity.

RESULTS—Age, BMI, waist, fat-free mass (ffm), and physical activity did not differ by ACE genotype. Fasting glucose and insulin were similar among genotypes, but 2-h glucose levels were higher in DD than in ID and II subjects (DD: 5.9 ± 1.7; ID: 5.7 ± 1.5; II: 5.6 ± 1.5 mmol/l) (P = 0.004). Participants with the DD genotype were more likely to have impaired glucose tolerance than those with the ID and II genotypes (13.1 vs. 8.7%; P = 0.02). Insulin sensitivity was lower in participants with the DD genotype than in those with the II genotype (136 ± 63 vs. 147 ± 65 µmol · min–1· kg ffm–1 · mmol–1 · l–1; P = 0.02). The presence of the D allele was associated with a trend, albeit not significant, for reduced insulin secretion during the oral glucose tolerance test (P = 0.07).

CONCLUSIONS—The ACE I/D polymorphism is associated with whole-body insulin sensitivity and with impaired glucose tolerance in our healthy population. These findings confirm potential interactions between the RAS and glucose metabolism.

Abbreviations: I/D, insertion/deletion • IGT, impaired glucose tolerance • OGTT, oral glucose tolerance test • RAS, renin-angiotensin system • RISC, Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.